← Back to patent-cliff list
CAS 104-55-2
Cinnamal3-Phenyl-2(E)-propenal
Codes: (I)101438-69-a, (I)263642-13-a
Application context (from source-drug indications)
Breast cancerPaclitaxel/Encequidar mesylateAdenocarcinomaPaclitaxel/Encequidar mesylateAngiosarcomaPaclitaxel/Encequidar mesylateSolid tumourPaclitaxel/Encequidar mesylatePancreatic cancerPaclitaxelNon-small cell lung cancerPaclitaxelHodgkin's diseasePaclitaxelSeminomaPaclitaxelOvarian cancerPaclitaxelBreast cancerPaclitaxel分离性焦虑R-fluoxetineAnxietyR-fluoxetineAnxiety disorderR-fluoxetine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Paclitaxel/Encequidar mesylate | Tier C — Watch / trade | - |
| Paclitaxel | Tier B — Position early | - |
| R-fluoxetine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Cinnamal→(2S,3S)-3-Amino-2-hydroxy-3-phenylpropanamide→Methyl (2S,3S)-3-amino-2-hydroxy-3-phenylpropanoate→alpha-Chlorobenzaldehyde→(4S,5R)-3-Benzoyl-2-[(4-methoxyphenyl)methyl]-4-phenyl-1,3-oxazolidine-5-carboxylic acid→Methyl (2S,3S)-3-benzamido-2-hydroxy-3-phenylpropanoate→Methyl (2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoate→1-(Dimethoxymethyl)-4-methoxybenzene→Methyl (4S,5R)-3-benzoyl-2-[(4-methoxyphenyl)methyl]-4-phenyl-1,3-oxazolidine-5-carboxylate→(2R,3S)-3-Amino-2-hydroxy-3-phenylpropanoic acid hydrochloride→(2R,3S)-3-Phenylisoserine methyl ester
Cinnamal→(2S,3S)-3-Amino-2-hydroxy-3-phenylpropanamide→Methyl (2S,3S)-3-amino-2-hydroxy-3-phenylpropanoate→alpha-Chlorobenzaldehyde→(4S,5R)-3-Benzoyl-2-[(4-methoxyphenyl)methyl]-4-phenyl-1,3-oxazolidine-5-carboxylic acid→Methyl (2S,3S)-3-benzamido-2-hydroxy-3-phenylpropanoate→Methyl (2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoate→1-(Dimethoxymethyl)-4-methoxybenzene→Methyl (4S,5R)-3-benzoyl-2-[(4-methoxyphenyl)methyl]-4-phenyl-1,3-oxazolidine-5-carboxylate→(2R,3S)-3-Amino-2-hydroxy-3-phenylpropanoic acid hydrochloride→(2R,3S)-3-Phenylisoserine methyl ester
3-Phenyl-2(E)-propenal→1,1-Diphenylmethylamine→1,1-Diphenyl-N-[(1E,2E)-3-phenylprop-2-en-1-ylidene]methanamine→4,4,4',4',5,5,5',5'-Octamethyl-2,2'-bi-1,3,2-dioxaborolane→1,1-Diphenyl-N-[(1E)-3-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propylidene]methanamine→1,1-Diphenyl-N-[(1E,3R)-3-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propylidene]methanamine→Aminomethane→N-[(1E)-3-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propylidene]methanamine→N-[(1E,3R)-3-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propylidene]methanamine→N-Methyl-3-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propan-1-amine→(3R)-N-Methyl-3-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propan-1-amine→(+/-)-n-Methyl-3-hydroxy-3-phenylpropylamine→(1R)-3-(Methylamino)-1-phenylpropan-1-ol→Sodium 3-(methylamino)-1-phenylpropan-1-olate→Sodium (1R)-3-(methylamino)-1-phenylpropan-1-olate→1-Chloro-4-(trifluoromethyl)benzene→(+/-)-N-Methyl-3-phenyl-[3-[4-(trifluoromethyl)phenoxy]propylamine]
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.